HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A two-step intensity-modulated radiation therapy method for nasopharyngeal cancer: the Kinki University experience.

AbstractOBJECTIVE:
The aim of this study was to analyze the clinical results of our adaptive radiation therapy scheme of a two-step intensity-modulated radiotherapy (IMRT) method for nasopharyngeal cancer (NPC) at Kinki University Hospital.
METHODS:
Between 2000 and 2007, 35 patients with Stage I-IVB NPC treated by IMRT were included. For all patients, treatment-planning computed tomography was done twice before and during IMRT to a total dose of 60-70 Gy/28-35 fractions (median 68 Gy). Chemotherapy (cisplatin 80 mg/m(2)/3 weeks x 1-3 courses) was given concurrently with IMRT for 31 patients.
RESULTS:
The 3- and 5-year overall survival rates for the 31 patients treated with concurrent chemotherapy were 88% and 83%, respectively. The 3- and 5-year loco-regional control rates for the 31 patients were 93% and 87%, respectively. Planning target volume delineation for the primary site or involved nodes was insufficient for three early cases, resulting in marginal recurrence in the three patients (9%). Except for one patient with early death, xerostomia scores at 1-2 years were: Grade 0, 11; Grade 1, 17; Grade 2, 5; Grade 3, 1.
CONCLUSIONS:
Excellent overall survival and loco-regional control rates were obtained by a two-step IMRT method with concurrent chemotherapy for NPC, although marginal recurrence was noted in some early cases.
AuthorsYasumasa Nishimura, Toru Shibata, Kiyoshi Nakamatsu, Shuichi Kanamori, Ryuta Koike, Mitsuru Okubo, Tatsuyuki Nishikawa, Izumi Tachibana, Masaya Tamura, Masahiko Okumura
JournalJapanese journal of clinical oncology (Jpn J Clin Oncol) Vol. 40 Issue 2 Pg. 130-8 (Feb 2010) ISSN: 1465-3621 [Electronic] England
PMID19841102 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Antineoplastic Agents
  • Cisplatin
Topics
  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Antineoplastic Agents (therapeutic use)
  • Cisplatin (therapeutic use)
  • Combined Modality Therapy
  • Female
  • Humans
  • Japan
  • Male
  • Middle Aged
  • Nasopharyngeal Neoplasms (drug therapy, mortality, radiotherapy)
  • Neoplasm Staging
  • Radiotherapy Dosage
  • Radiotherapy, Intensity-Modulated
  • Retrospective Studies
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: